<!doctype html>
<html lang="en">
  <head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <link href="https://cdn.jsdelivr.net/npm/bootstrap@5.3.1/dist/css/bootstrap.min.css" rel="stylesheet">
    <style>
        body{background-color:slategrey};
    </style>
  </head>
<body>
<div class="container" style="margin-top:20px; width:1024px">

<div class="row">
    
    <div class="col"><img style="width:310px; margin-top:10px" src="table.001.dbg.png"/></div>
    
    <div class="col"><img style="width:310px; margin-top:10px" src="table.002.dbg.png"/></div>
    
    <div class="col"><img style="width:310px; margin-top:10px" src="table.003.dbg.png"/></div>
    
    <div class="col"><img style="width:310px; margin-top:10px" src="table.004.dbg.png"/></div>
    
    <div class="col"><img style="width:310px; margin-top:10px" src="table.005.dbg.png"/></div>
    
</div>


    <table class="table table-bordered row" width="500px">
        <tr>
            <td style="background:lightblue" colspan="5">Table 1. Furan Replacement SAR</td>
        </tr>
        
        <tr>
            
            <td>Compound</td>
            
            <td>R2</td>
            
            <td>IL-1 IC50 (M)c</td>
            
            <td>cLogP cLogD</td>
            
            <td>LLEb</td>
            
        </tr>
        
        <tr>
            
            <td>1</td>
            
            <td>[CCO]</td>
            
            <td>0.029  0.015 (n=50)</td>
            
            <td>2.9±0.5</td>
            
            <td>7.0</td>
            
        </tr>
        
        <tr>
            
            <td>2</td>
            
            <td>[CCO]</td>
            
            <td>0.44</td>
            
            <td>2.6±0.7</td>
            
            <td>5.7</td>
            
        </tr>
        
        <tr>
            
            <td>3</td>
            
            <td>[CCO]</td>
            
            <td>1.79</td>
            
            <td>3.3±1.2</td>
            
            <td>4.5</td>
            
        </tr>
        
        <tr>
            
            <td>4</td>
            
            <td>[CCO]</td>
            
            <td>1.33</td>
            
            <td>2.7±0.5</td>
            
            <td>5.4</td>
            
        </tr>
        
        <tr>
            
            <td>5</td>
            
            <td>[CCO]</td>
            
            <td>1.08</td>
            
            <td>2.2±0.3</td>
            
            <td>5.7</td>
            
        </tr>
        
        <tr>
            
            <td>6</td>
            
            <td>[CCO]</td>
            
            <td>1.54</td>
            
            <td>2.1±0.4</td>
            
            <td>5.4</td>
            
        </tr>
        
        <tr>
            
            <td>1</td>
            
            <td>[CCO]</td>
            
            <td>0.96</td>
            
            <td>1.6±0.1</td>
            
            <td>5.9</td>
            
        </tr>
        
        <tr>
            
            <td>8</td>
            
            <td>[CCO]</td>
            
            <td>3.66</td>
            
            <td>2.6±0.6</td>
            
            <td>4.8</td>
            
        </tr>
        
        <tr>
            
            <td>9</td>
            
            <td>[CCO]</td>
            
            <td>0.43</td>
            
            <td>2.8±0.7</td>
            
            <td>5.7</td>
            
        </tr>
        
        <tr>
            
            <td>10</td>
            
            <td>[CCO]</td>
            
            <td>2.31</td>
            
            <td>2.1±0</td>
            
            <td>5.6</td>
            
        </tr>
        
        <tr>
            
            <td>11</td>
            
            <td>[CCO]</td>
            
            <td>2.55</td>
            
            <td>2.4±0.4</td>
            
            <td>5.2</td>
            
        </tr>
        
        <tr>
            
            <td>12</td>
            
            <td>[CCO]</td>
            
            <td>0.34</td>
            
            <td>2.1±0.3</td>
            
            <td>6.2</td>
            
        </tr>
        
        <tr>
            
            <td>13</td>
            
            <td>[CCO]</td>
            
            <td>0.21</td>
            
            <td>1.8±0.4</td>
            
            <td>6.3</td>
            
        </tr>
        
        <tr>
            <td style="background:#cecece" colspan="5">'Inhibition of the NLRP3 inflammasome pathway was assessed by quantifying IL-1 release from lipopolysaccharide (LPS) + nigericin. stimulated hPBMCs (n = 1 for all compounds except compound 1) which is reported as the geometric mean  SD). LLE was calculated potency was also observed in a number of ortho substituted</td>
        </tr>
    </table>
    <div class="row" style="margin-top:10px"></div>

    <table class="table table-bordered row" width="500px">
        <tr>
            <td style="background:lightblue" colspan="5">Table 2. Functionalized Pyrazole SAR</td>
        </tr>
        
        <tr>
            
            <td>Compound</td>
            
            <td>R2</td>
            
            <td>IL-1 IC50 (M)a</td>
            
            <td>cLogP cLogD</td>
            
            <td>LLEb</td>
            
        </tr>
        
        <tr>
            
            <td>14</td>
            
            <td>[CCO]</td>
            
            <td>0.086</td>
            
            <td>2.6±0.9</td>
            
            <td>6.2</td>
            
        </tr>
        
        <tr>
            
            <td>15</td>
            
            <td>[CCO]</td>
            
            <td>2.57</td>
            
            <td>2.4±0.5</td>
            
            <td>5.1</td>
            
        </tr>
        
        <tr>
            
            <td>16</td>
            
            <td>[CCO]</td>
            
            <td>0.41</td>
            
            <td>3.0±0.9</td>
            
            <td>5.5</td>
            
        </tr>
        
        <tr>
            
            <td>17</td>
            
            <td>[CCO]</td>
            
            <td>0.063  0.042 (n=28)</td>
            
            <td>2.0±0.4</td>
            
            <td>6.7</td>
            
        </tr>
        
        <tr>
            
            <td>18</td>
            
            <td>[CCO]</td>
            
            <td>0.43</td>
            
            <td>2.1±0.4</td>
            
            <td>6.0</td>
            
        </tr>
        
        <tr>
            
            <td>19</td>
            
            <td>[CCO]</td>
            
            <td>6.2</td>
            
            <td>1.8±0</td>
            
            <td>5.2</td>
            
        </tr>
        
        <tr>
            <td style="background:#cecece" colspan="5">'Inhibition of the NLRP3 inflammasome pathway was assessed by quantifying IL-1 release from LPS + nigericin stimulated hPBMCs (n = 1 for all compounds except compound 17 which is reported as geometric mean  SD). LLE was calculated using the following equation: LLE = pICso IL-1 - cLogD.</td>
        </tr>
    </table>
    <div class="row" style="margin-top:10px"></div>

    <table class="table table-bordered row" width="500px">
        <tr>
            <td style="background:lightblue" colspan="5">Table 3. 6,7-Dihydro-5H-pyrazolo[5,1-b][1,3]oxazine Substitutions</td>
        </tr>
        
        <tr>
            
            <td>Compound</td>
            
            <td>R3</td>
            
            <td>IL-1 IC50(M)c</td>
            
            <td>cLogP cLogD</td>
            
            <td>LLEd</td>
            
        </tr>
        
        <tr>
            
            <td>GDC-2394 (20)</td>
            
            <td>H .N.</td>
            
            <td>0.0054  0.004 (n=16)</td>
            
            <td>1.1±0.1</td>
            
            <td>8.2</td>
            
        </tr>
        
        <tr>
            
            <td>R-20</td>
            
            <td>[CCO]</td>
            
            <td>1.40</td>
            
            <td>1.1±0.1</td>
            
            <td>5.8</td>
            
        </tr>
        
        <tr>
            
            <td>21a</td>
            
            <td>[CCO]</td>
            
            <td>0.013  0.008 (n=3)</td>
            
            <td>1.6±0.4</td>
            
            <td>7.5</td>
            
        </tr>
        
        <tr>
            
            <td>22a</td>
            
            <td>[CCO]</td>
            
            <td>0.012  0.01 (n=3)</td>
            
            <td>1.2±0.1</td>
            
            <td>7.8</td>
            
        </tr>
        
        <tr>
            
            <td>23b</td>
            
            <td>[CCO]</td>
            
            <td>2.40</td>
            
            <td>1.7 -0.1</td>
            
            <td>5.7</td>
            
        </tr>
        
        <tr>
            <td style="background:#cecece" colspan="5">'Data reported for the most potent stereoisomer. bTested as the racemate. 'Inhibition of the NLRP3 inflammasome pathway was assessed by quantifying IL-1 release from LPS + nigericin stimulated hPBMCs (reported as geometric mean  SD; compounds R-20 and 23 are reported as n = 1). dLLE was calculated using the following equation: LLE = pICso IL-1 - cLogD.</td>
        </tr>
    </table>
    <div class="row" style="margin-top:10px"></div>

    <table class="table table-bordered row" width="500px">
        <tr>
            <td style="background:lightblue" colspan="5">Table 4. Inhibition of IL-1 by GDC-2394 (20) Following NLRP3 Activation with LPS plus ATP in Human and Mouse WBa species human</td>
        </tr>
        
        <tr>
            
            <td>mouse</td>
            
            <td>0.10±0.02</td>
            
            <td>0.18±0.03</td>
            
            <td>0.39±0.07</td>
            
            <td>10</td>
            
        </tr>
        
        <tr>
            <td style="background:#cecece" colspan="5">'Reported as geometric means of the indicated number (n) of blood. donors.</td>
        </tr>
    </table>
    <div class="row" style="margin-top:10px"></div>

    <table class="table table-bordered row" width="500px">
        <tr>
            <td style="background:lightblue" colspan="4">Table 5. Human Dose Predictions for Compounds 1, 17, and GDC-2394 (20)</td>
        </tr>
        
        <tr>
            
            <td>compound</td>
            
            <td>1</td>
            
            <td>17</td>
            
            <td>GDC-2394 (20)</td>
            
        </tr>
        
        <tr>
            
            <td>CL (mL/min/kg)</td>
            
            <td>0.8</td>
            
            <td>1.1</td>
            
            <td>1.5</td>
            
        </tr>
        
        <tr>
            
            <td>Vss (L kg-l)</td>
            
            <td>0.1</td>
            
            <td>0.1</td>
            
            <td>0.3</td>
            
        </tr>
        
        <tr>
            
            <td>t1/2 (h)</td>
            
            <td>1.8</td>
            
            <td>1.6</td>
            
            <td>2.3</td>
            
        </tr>
        
        <tr>
            
            <td>F (%)</td>
            
            <td>57</td>
            
            <td>25</td>
            
            <td>61</td>
            
        </tr>
        
        <tr>
            
            <td>QD dose covering IC50 Ctrough (mg)</td>
            
            <td>850</td>
            
            <td>1200</td>
            
            <td>500</td>
            
        </tr>
        
        <tr>
            
            <td>QD dose covering IC9o Ctrough (mg)</td>
            
            <td>7000</td>
            
            <td>9500</td>
            
            <td>2400</td>
            
        </tr>
        
        <tr>
            <td style="background:#cecece" colspan="4"></td>
        </tr>
    </table>
    <div class="row" style="margin-top:10px"></div>


<div></body>
</html>